Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2007

01-03-2007 | Case Report

Large Cell Lymphoma Presenting as a Flare of Colitis in a Patient with Common Variable Immune Deficiency

Authors: Megan Dunnigan, Harris Yfantis, Aaron P. Rapoport, Keya Hosseinzadeh, Christopher D. Gocke, Raymond K. Cross

Published in: Digestive Diseases and Sciences | Issue 3/2007

Login to get access

Excerpt

Common variable immune deficiency (CVID) is one of the most common primary immunodeficiencies, with an incidence worldwide ranging from 1 in 25,000 to 1 in 100,000 [1]. CVID is found equally among men and women and has a bimodal age distribution with peaks occurring between 1 and 5 years and between 18 and 25 years of age [2]. The pathogenesis is not well understood; however, defects exist in B-cell differentiation [3, 4], T-cell function and signaling [57], and immunoglobulin secretion [8]. The multiple immune defects present in CVID lead to a myriad of clinical symptoms including recurrent sinopulmonary infections, chronic lung disease, autoimmune diseases, liver and gastrointestinal disorders, lymphomas, and solid organ tumors [4, 9, 10]. …
Literature
1.
go back to reference Hammarstrom L, Vorechovsky I, Webster D (2000) Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 120:225–231PubMedCrossRef Hammarstrom L, Vorechovsky I, Webster D (2000) Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 120:225–231PubMedCrossRef
2.
go back to reference Hermaszewski RA, Webster AD (1993) Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 86:31–42PubMed Hermaszewski RA, Webster AD (1993) Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 86:31–42PubMed
3.
go back to reference Saiki O, Ralph P, Cunningham-Rundles C, et al. (1982) Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci USA 79:6008–6012PubMedCrossRef Saiki O, Ralph P, Cunningham-Rundles C, et al. (1982) Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci USA 79:6008–6012PubMedCrossRef
4.
go back to reference Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48PubMedCrossRef Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48PubMedCrossRef
5.
go back to reference Cunningham-Rundles S, Cunningham-Rundles C, Siegal FP, et al. (1981) Defective cellular immune response in vitro in common variable immunodeficiency. J Clin Immunol 65–72 Cunningham-Rundles S, Cunningham-Rundles C, Siegal FP, et al. (1981) Defective cellular immune response in vitro in common variable immunodeficiency. J Clin Immunol 65–72
6.
go back to reference Stagg AJ, Funauchi M, Knight SC, et al. (1994) Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 96:48–53PubMedCrossRef Stagg AJ, Funauchi M, Knight SC, et al. (1994) Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 96:48–53PubMedCrossRef
7.
go back to reference Kondratenko I, Amlot PL, Webster AD, et al. (1997) Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells. MRC Immunodeficiency Group. Clin Exp Immunol 108:9–13PubMedCrossRef Kondratenko I, Amlot PL, Webster AD, et al. (1997) Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells. MRC Immunodeficiency Group. Clin Exp Immunol 108:9–13PubMedCrossRef
8.
go back to reference Bryant A, Calver NC, Toubi E, et al. (1990) Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol 56:239–248PubMedCrossRef Bryant A, Calver NC, Toubi E, et al. (1990) Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol 56:239–248PubMedCrossRef
9.
go back to reference Cunningham-Rundles C (1989) Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 9:22–33PubMedCrossRef Cunningham-Rundles C (1989) Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 9:22–33PubMedCrossRef
10.
go back to reference Sneller MC, Strober W, Eisenstein E, et al. (1993) NIH conference. New insights into common variable immunodeficiency. Ann Intern Med 118:720–730PubMed Sneller MC, Strober W, Eisenstein E, et al. (1993) NIH conference. New insights into common variable immunodeficiency. Ann Intern Med 118:720–730PubMed
11.
go back to reference Washington K, Stenzel TT, Buckley RH, et al. (1996) Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol 20:1240–1252PubMedCrossRef Washington K, Stenzel TT, Buckley RH, et al. (1996) Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol 20:1240–1252PubMedCrossRef
12.
go back to reference Lai Ping So A, Mayer L (1997) Gastrointestinal manifestations of primary immunodeficiency disorders. Semin Gastrointest Dis 8:22–32PubMed Lai Ping So A, Mayer L (1997) Gastrointestinal manifestations of primary immunodeficiency disorders. Semin Gastrointest Dis 8:22–32PubMed
13.
go back to reference Kutukculer N, Yagci RV, Aydogdu S, et al. (2001) Chronic inflammatory bowel disease in a patient with common variable immunodeficiency. Turk J Pediatr 43:88–90PubMed Kutukculer N, Yagci RV, Aydogdu S, et al. (2001) Chronic inflammatory bowel disease in a patient with common variable immunodeficiency. Turk J Pediatr 43:88–90PubMed
14.
go back to reference Feugier P, Van Hoof A, Sebban C, et al. (2005) Long-term results of the R-CHOP Study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol 23:4117–4126PubMedCrossRef Feugier P, Van Hoof A, Sebban C, et al. (2005) Long-term results of the R-CHOP Study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol 23:4117–4126PubMedCrossRef
15.
go back to reference Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, et al. (1987) Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 7:294–299PubMedCrossRef Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, et al. (1987) Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 7:294–299PubMedCrossRef
16.
go back to reference Bernstein CN, Blanchard JF, Kliewer E, et al. (2001) Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91:854–862PubMedCrossRef Bernstein CN, Blanchard JF, Kliewer E, et al. (2001) Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91:854–862PubMedCrossRef
17.
go back to reference Palli D, Trallori G, Bagnoli S, et al. (2000) Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology 119:647–653PubMedCrossRef Palli D, Trallori G, Bagnoli S, et al. (2000) Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology 119:647–653PubMedCrossRef
18.
go back to reference Farrell RJ, Ang Y, Kileen P, et al. (2000) Increased incidence of non–Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut 47:514–519PubMedCrossRef Farrell RJ, Ang Y, Kileen P, et al. (2000) Increased incidence of non–Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut 47:514–519PubMedCrossRef
19.
go back to reference Arseneau KO, Stukenborg GJ, Connors AF Jr, et al. (2001) The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients. Inflamm Bowel Dis 7:106–112PubMedCrossRef Arseneau KO, Stukenborg GJ, Connors AF Jr, et al. (2001) The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients. Inflamm Bowel Dis 7:106–112PubMedCrossRef
20.
go back to reference Loftus EV Jr, Tremaine WJ, Habermann TM, et al. (2000) Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol 95:2308–2312PubMedCrossRef Loftus EV Jr, Tremaine WJ, Habermann TM, et al. (2000) Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol 95:2308–2312PubMedCrossRef
21.
go back to reference Lewis JD, Bilker WB, Brensinger C, et al. (2001) Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 121:1080–1087PubMedCrossRef Lewis JD, Bilker WB, Brensinger C, et al. (2001) Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 121:1080–1087PubMedCrossRef
22.
go back to reference Askling J, Brandt L, Lapidus A, et al. (2005) Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 54:617–622PubMedCrossRef Askling J, Brandt L, Lapidus A, et al. (2005) Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 54:617–622PubMedCrossRef
Metadata
Title
Large Cell Lymphoma Presenting as a Flare of Colitis in a Patient with Common Variable Immune Deficiency
Authors
Megan Dunnigan
Harris Yfantis
Aaron P. Rapoport
Keya Hosseinzadeh
Christopher D. Gocke
Raymond K. Cross
Publication date
01-03-2007
Published in
Digestive Diseases and Sciences / Issue 3/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9299-6

Other articles of this Issue 3/2007

Digestive Diseases and Sciences 3/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.